— Know what they know.
Not Investment Advice

ATNM AMEX

Actinium Pharmaceuticals, Inc.
1W: -2.5% 1M: +17.0% 3M: +21.8% YTD: -14.6% 1Y: -26.9% 3Y: -81.1% 5Y: -87.9%
$1.17
+0.02 (+1.74%)
 
Weekly Expected Move ±12.6%
$1 $1 $1 $1 $1
AMEX · Healthcare · Biotechnology · Tech Score Neutral · Power 56 · $36.7M mcap · 31M float · 0.442% daily turnover · Short 37% of daily vol

Supply Chain Overview

1 relationships
1
As Filer
counterparties named
0
As Counterparty
mentioned by others
1
Rel. Types
2022-04-13
Earliest Filing
2022-04-13
Latest Filing
partner: 1

Counterparties (Filed by ATNM)

1 relationships

Companies named in ATNM's SEC 8-K filings as business counterparties.

Counterparty Ticker Relationship Summary Filing Date SEC
Immedica Pharma AB — partner License and supply agreement for commercialization of Iomab-B in EUMENA 2022-04-13 View
Recent 8-K Filings (17)
Filing Date Description Type SEC
2026-08-14 Delisting Notice; Regulation FD; Exhibits View
2026-06-18 Other Events View
2026-05-29 Delisting Notice; Regulation FD; Exhibits View
2026-03-26 Shareholder Vote View
2026-02-13 Departure/Election of Directors; Appointment of Officers View
2025-11-26 Departure/Election of Directors; Appointment of Officers; Submission of Matters to a Vote of Securit View
2025-05-09 Changes in Registrant's Certifying Accountant; Financial Statements and Exhibits View
2024-11-27 Departure/Election of Directors; Appointment of Officers; Submission of Matters to a Vote of Securit View
2024-11-05 Departure/Election of Directors; Appointment of Officers; Other Events; Financial Statements and Exh View
2023-03-10 Regulation FD Disclosure View
2023-02-21 Regulation FD Disclosure; Financial Statements and Exhibits View
2022-12-30 Departure/Election of Directors; Appointment of Officers; Submission of Matters to a Vote of Securit View
2022-12-09 Other Events View
2022-10-31 Regulation FD Disclosure; Financial Statements and Exhibits View
2022-04-13 Entry into Material Definitive Agreement Agreement View
2021-11-09 Departure/Election of Directors; Appointment of Officers; Submission of Matters to a Vote of Securit View
2021-09-23 Departure/Election of Directors; Appointment of Officers; Regulation FD Disclosure; Financial Statem View
Data extracted from SEC EDGAR 8-K filings using NLP. Relationships are as disclosed in filing text. Covers 2021–2026. View on SEC EDGAR

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms